Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahrokh F Shariat

Showing results (11-20 of 2,054) with videos related to

Pageof 206
Sort By:
Nature Reviews. Urology|February 24, 2025
Advancing perioperative care in MIBC: insights from NIAGARAStephan Brönimann, Shahrokh F Shariat
European Urology|March 15, 2016
Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerRomain Mathieu, Shahrokh F Shariat
European Urology|June 11, 2017
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementDavid D'Andrea, Shahrokh F Shariat
European Urology|May 2, 2022
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder CancerEkaterina Laukhtina, Shahrokh F Shariat
European Urology|November 25, 2023
Re: The Complete Sequence of a Human Y ChromosomeBernhard Englinger, Shahrokh F Shariat
Cancer|July 7, 2011
Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployedGuru Sonpavde, Shahrokh F Shariat
European Urology|September 4, 2013
Words of wisdom: Re: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trialEvanguelos Xylinas, Shahrokh F Shariat
European Urology|February 26, 2013
Renal cancer therapy: going forward by going backward?Malte Rieken, Shahrokh F Shariat
Translational Andrology and Urology|October 28, 2016
Contemporary concepts and controversies in the diagnosis and management of urothelial carcinomaShahrokh F Shariat, Romain Mathieu
The Lancet. Oncology|July 5, 2012
Biomarkers in personalised treatment of renal-cell carcinomaShahrokh F Shariat, Evanguelos Xylinas
Pageof 206

Showing results (11-20 of 2,054) with videos related to

Sort By:
Pageof 206
Nature Reviews. Urology|February 24, 2025
Advancing perioperative care in MIBC: insights from NIAGARAStephan Brönimann, Shahrokh F Shariat
European Urology|March 15, 2016
Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerRomain Mathieu, Shahrokh F Shariat
European Urology|June 11, 2017
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node InvolvementDavid D'Andrea, Shahrokh F Shariat
European Urology|May 2, 2022
Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder CancerEkaterina Laukhtina, Shahrokh F Shariat
European Urology|November 25, 2023
Re: The Complete Sequence of a Human Y ChromosomeBernhard Englinger, Shahrokh F Shariat
Cancer|July 7, 2011
Preoperative chemotherapy for bladder cancer: a standard waits to be optimally deployedGuru Sonpavde, Shahrokh F Shariat
European Urology|September 4, 2013
Words of wisdom: Re: Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trialEvanguelos Xylinas, Shahrokh F Shariat
European Urology|February 26, 2013
Renal cancer therapy: going forward by going backward?Malte Rieken, Shahrokh F Shariat
Translational Andrology and Urology|October 28, 2016
Contemporary concepts and controversies in the diagnosis and management of urothelial carcinomaShahrokh F Shariat, Romain Mathieu
The Lancet. Oncology|July 5, 2012
Biomarkers in personalised treatment of renal-cell carcinomaShahrokh F Shariat, Evanguelos Xylinas
Pageof 206